BI Trail 1160.108
Laufzeit: 01.01.2017 - 31.12.2020
Kurzfassung
Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to les than 18 years
Laufzeit: 01.01.2017 - 31.12.2020
Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to les than 18 years
